139 related articles for article (PubMed ID: 12045262)
1. p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling.
Sturm A; Itoh J; Jacobberger JW; Fiocchi C
J Clin Invest; 2002 Jun; 109(11):1481-92. PubMed ID: 12045262
[TBL] [Abstract][Full Text] [Related]
2. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.
Sturm A; Rilling K; Baumgart DC; Gargas K; Abou-Ghazalé T; Raupach B; Eckert J; Schumann RR; Enders C; Sonnenborn U; Wiedenmann B; Dignass AU
Infect Immun; 2005 Mar; 73(3):1452-65. PubMed ID: 15731043
[TBL] [Abstract][Full Text] [Related]
3. p53-independent regulation of cyclin B1 in normal human fibroblasts during UV-induced G2-arrest.
Vincent F; Deplanque G; Ceraline J; Duclos B; Bergerat JP
Biol Cell; 1999 Dec; 91(9):665-74. PubMed ID: 10668097
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of the phosphoinositide 3-kinase pathway in human lamina propria T lymphocytes.
Braunstein J; Autschbach F; Giese T; Lasitschka F; Heidtmann A; Sido B; Funke B; Reiser C; Schröder AJ; Nebl G; Samstag Y; Meuer SC
Clin Exp Immunol; 2008 Mar; 151(3):496-504. PubMed ID: 18234058
[TBL] [Abstract][Full Text] [Related]
6. Different expression profiles of human cyclin B1 in normal PHA-stimulated T lymphocytes and leukemic T cells.
Viallard JF; Lacombe F; Dupouy M; Ferry H; Belloc F; Reiffers J
Cytometry; 2000 Feb; 39(2):117-25. PubMed ID: 10679729
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
[TBL] [Abstract][Full Text] [Related]
8. Activation of MAP-2 kinase activity by the CD2 receptor in Jurkat T cells can be reversed by CD45 phosphatase.
Nel AE; Ledbetter JA; Williams K; Ho P; Akerley B; Franklin K; Katz R
Immunology; 1991 Jun; 73(2):129-33. PubMed ID: 1676984
[TBL] [Abstract][Full Text] [Related]
9. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.
Bai M; Vlachonikolis J; Agnantis NJ; Tsanou E; Dimou S; Nicolaides C; Stefanaki S; Pavlidis N; Kanavaros P
Mod Pathol; 2001 Nov; 14(11):1105-13. PubMed ID: 11706071
[TBL] [Abstract][Full Text] [Related]
10. Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis.
Sturm A; Leite AZ; Danese S; Krivacic KA; West GA; Mohr S; Jacobberger JW; Fiocchi C
Gut; 2004 Nov; 53(11):1624-31. PubMed ID: 15479683
[TBL] [Abstract][Full Text] [Related]
11. Relationship between proliferation and susceptibility to CD95- and CD2-mediated apoptosis in stimulated primary T lymphocytes: T cells manifesting proliferative unresponsiveness are preferentially susceptible to CD95-mediated apoptosis.
Mollereau B; Blanchard D; Déas O; Dumont C; Métivier D; Bernard A; McGrew JT; Charpentier B; Vazquez A; Senik A
J Immunol; 1997 Sep; 159(6):2668-77. PubMed ID: 9300686
[TBL] [Abstract][Full Text] [Related]
12. Stimulation through the TCR/CD3 complex up-regulates the CD2 surface expression on human T lymphocytes.
Alberola-Ila J; Places L; de la Calle O; Romero M; Yagüe J; Gallart T; Vives J; Lozano F
J Immunol; 1991 Feb; 146(4):1085-92. PubMed ID: 1671400
[TBL] [Abstract][Full Text] [Related]
13. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line.
Badie C; Bourhis J; Sobczak-Thépot J; Haddada H; Chiron M; Janicot M; Janot F; Tursz T; Vassal G
Br J Cancer; 2000 Feb; 82(3):642-50. PubMed ID: 10682678
[TBL] [Abstract][Full Text] [Related]
14. CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling.
Kanner SB; Damle NK; Blake J; Aruffo A; Ledbetter JA
J Immunol; 1992 Apr; 148(7):2023-9. PubMed ID: 1372020
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the G2/M transition by p53.
Taylor WR; Stark GR
Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
[TBL] [Abstract][Full Text] [Related]
16. Age-associated decline in cdk1 activity delays cell cycle progression of human T lymphocytes.
Quadri RA; Arbogast A; Phelouzat MA; Boutet S; Plastre O; Proust JJ
J Immunol; 1998 Nov; 161(10):5203-9. PubMed ID: 9820491
[TBL] [Abstract][Full Text] [Related]
17. Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes.
Koulova L; Yang SY; Dupont B
J Immunol; 1990 Oct; 145(7):2035-43. PubMed ID: 1697875
[TBL] [Abstract][Full Text] [Related]
18. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
Hsieh WT; Huang KY; Lin HY; Chung JG
Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
[TBL] [Abstract][Full Text] [Related]
19. Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line.
Rothstein DM; Yamada A; Schlossman SF; Morimoto C
J Immunol; 1991 Feb; 146(4):1175-83. PubMed ID: 1671403
[TBL] [Abstract][Full Text] [Related]
20. CD2 activation of human lamina propria lymphocytes reduces CD3 responsiveness.
Ebert EC
Immunology; 2006 Jan; 117(1):71-7. PubMed ID: 16423042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
